Piramal Pharma Limited (BOM:543635)

India flag India · Delayed Price · Currency is INR
152.95
-3.20 (-2.05%)
At close: Mar 2, 2026
-19.48%
Market Cap 202.24B
Revenue (ttm) 88.71B
Net Income (ttm) -1.64B
Shares Out n/a
EPS (ttm) -1.24
PE Ratio n/a
Forward PE 91.74
Dividend 0.14 (0.09%)
Ex-Dividend Date Jul 16, 2025
Volume 242,744
Average Volume 143,624
Open 142.95
Previous Close 156.15
Day's Range 142.95 - 154.85
52-Week Range 142.95 - 241.00
Beta n/a
RSI 36.21
Earnings Date May 14, 2026

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 5,476
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543635
Full Company Profile

Financial Performance

In fiscal year 2025, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.

Financial Statements

News

There is no news available yet.